Veru Inc. is an oncology and urology biopharmaceutical company developing and commercializing novel medicines for the prostate cancer continuum of care and urology specialty pharmaceuticals.
October 2, 2019
Watch the replay of the webcast of our presentation at the 2019 Cantor Fitzgerald Global Healthcare Conference.
(View Slide Deck)
Listen to other presentations and conference calls
We’re looking forward to presenting at the upcoming 2018 Jefferies Healthcare Conference Presentation. As soon as the conference starts, the link will be available. See you there!
September 23, 2019
Veru Announces Full Enrollment of Phase 2 Trial in Men with Prostate Cancer Treatment Induced Hot Flashes
August 28, 2019
Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York